Clinical Trials Directory

Trials / Completed

CompletedNCT03300648

Treating Brain Swelling in Pediatric Cerebral Malaria

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
57 (actual)
Sponsor
Michigan State University · Academic / Other
Sex
All
Age
6 Months – 12 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the effectiveness of two interventions in Malawian children with cerebral malaria at high risk of death. One-third of the participants will receive treatment as usual, one-third will receive treatment as usual and be placed on a mechanical ventilator, and one-third will receive treatment as usual plus intravenous hypertonic saline.

Detailed description

An important mechanism of death in children with cerebral malaria is diffuse cerebral swelling, cerebral herniation, compression of the brainstem respiratory center, and respiratory arrest. In those who survive their illness without specific interventions, reversal of diffuse cerebral swelling is rapid. Mechanical ventilation may help to preserve life while diffuse brain swelling diminishes. Intravenous hypertonic saline may work as an osmotic diuretic, directly decreasing brain swelling.

Conditions

Interventions

TypeNameDescription
OTHERMechanical ventilationIntubation and mechanical ventilation for a maximum of 7 days
DRUGHypertonic salineIntravenous 3 percent hypertonic saline for a maximum of 7 days

Timeline

Start date
2018-01-08
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2017-10-03
Last updated
2025-03-17
Results posted
2025-03-17

Locations

1 site across 1 country: Malawi

Regulatory

Source: ClinicalTrials.gov record NCT03300648. Inclusion in this directory is not an endorsement.